An independent British medical watchdog says the first treatment proven to help people with the deadliest form of skin cancer live longer is too expensive.
An independent British medical watchdog says the first treatment proven to help people with the deadliest form of skin cancer is too expensive to be used by the U.K.'s health care system, a recommendation critics called a potential death sentence.
